Molecular modeling of the endogenous peptide Leu-Ser-Ala-Leu, pindolol, 5-hydroxytryptamine and their interactions with the human 5-hydroxytryptamine(1B) (5-HT(1B)) receptor

Receptors and Channels

Volumn 6, Issue 1, 1998, Pages 31-50

  Kristiansen, Kurt ^a   Edvardsen, Øyvind ^a   Dahl, Svein G ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

5 HT(1B) receptor; 5 Hydroxytryptamine; Leu Ser Ala Leu; Molecular modeling; Pindolol; Receptor binding; Sequence alignment

Indexed keywords

PEPTIDE; PINDOLOL; SEROTONIN; SEROTONIN 1B RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; HYDROGEN BOND; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; SIMULATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; ELECTROSTATICS; HUMANS; HYDROGEN BONDING; LIGANDS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; OLIGOPEPTIDES; PINDOLOL; PROTEIN CONFORMATION; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN; THERMODYNAMICS;

EID: 0031845896     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Bairoch A and Boeckmann B (1991) Nucleic Acids Res 19 2247-2249.
2. Baldwin JM (1993) EMBO J 12 1693-1703.
3. Ballesteros JA and Weinstein H (1994) Methods Neurosci 25 366-428.
4. Barak LS Tiberi M Freedman NJ Kwatra MM Lefkowitz RJ and Caron MG (1994) J Biol Chem 269 2790-2795.
5. Befort K Tabbara L Kling D Maigret B and Kieffer BL (1996) J Biol Chem 271 10 161-10 168.
6. Beinborn M Lee Y-M McBride EW Quinn SM and Kopin AS (1993) Nature 362 348-350.
7. Bernstein FC Koetzle TF Williams GJB Meyer EF JrBrice MD Rodgers JR Kennard O Shimanouchi T and Tasumi M (1977) J Mol Biol 112 535-542.
8. Cho W Taylor LP Mansour A and Akil H (1995) J Neurochem 65 2105-2115.
9. Chou PY and Fasman GD (1978) Annu Rev Biochem 47 251-276.
10. Choudhary MS Craigo S and Roth BL (1993) Mol Pharmacol 43 755-761.
11. Dahl SG and Edvardsen Ø (1994) "Molecular modeling of dopamine receptors" in Dopamine receptors and transporters. Pharmacology. Structure and Function (ed. Niznik HB) pp. 265-281 Marcel Decker Inc. New York, Basel, Hong Kong,
12. Donnelly D Findlay JBC and Blundell TL (1994) Recept Channel 2 61-78.
13. Edvardsen Ø and Dahl SG (1991) Mol Brain Res 9 31-37
14. Edvardsen Ø Sylte I and Dahl SG (1992) Mol Brain Res 14 166-178.
15. Edvardsen Ø and Dahl SG (1994) Mol Brain Res 27 265-274.
16. Fanelli F Menziani MC and Benedetti PGD (1995) Protein Eng 8 557-564.
17. Ferrin TE Huang CC Jarvis LE and Langndge R (1988) J Mol Graphics 6 13-27, 36-37.
18. Genetics Computer Group(1994) Program manual for the Wisconsin Package Version 8 September 1994.
19. Gerald C Adham N Kao H-T Olsen MA Laz TM Schechter LE Bard JA Vaysse PJ-J Hartig PR Branchek TA and Weinshank RL (1995) EMBO J 14 2806-2815.
20. Glennon RA Hong SS Dukat M Teitler M and Davis K (1994) J Med Chem 37 2828-2830.
21. Glennon RA Dukat M Westkaemper RB Ismaiel AM Izzarelli DG and Parker EM (1996) Mol Pharmacol 49 198-206.
22. Graanaes C Nordvall G and Larhammar D (1996) Nordic-Baltic Symposium on Heptahelix Receptors August 15-16 S12(Abstract).
23. Harug PR Hoyer D Humphrey PPA and Martin GR (1996) Trends Pharmacol Sci 17 103-105.
24. Henderson R Baldwin JM Ceska TA Zemlin F Beckman E and Downing KH (1990) J Biol Chem 213 899-929.
25. Ho BY Karschin A Branchek T Davidson N and Lester HA (1992) FEBS Lett 312 259-262.
26. Hoyer D Clarke DE Fozard JR Hartig PR Martin GR Mylecharane EJ Saxena PR and Humphrey PPA (1994) Pharmacol Rev 46 157-203.
27. Jakubik J and Tucek S (1995) Eur J Pharmacol Mol Pharmacol Sect 289 311-319.
28. King FD Brown AM Gaster LM Kaumann AJ Medhurst AD Parker SG Parsons AA Patch TL and Raval P (1993) J Med Chem 36 1918-1919.
29. Kolakowski Jr LF (1994) Recept Channel 2 1-7 (www http.// receptor.mgh harvard edu/GCRDB_paper.html).
30. Kristiansen K Dahl SG and Edvardsen Ø (1996) Proteins 26 81-94.
31. Kristiansen K and Dahl SG (1996) Eur J Pharmacol 306 195-210.
32. Kuipers W Van Wijngaarden I and Ijzerman AP (1994) Drug Des Discov 11 231-249.
33. Macor JE Blank DH Fox CB Lebel LA Newman ME Post RJ Ryan K Schmidt AW Schulz DW and Koe BK (1994) J Med Chem 37 2509-2512.
34. MaloneyHuss K and Lybrand TP (1992) J Mol Biol 225 859-871.
35. Mane J Maigret B Joseph M-P Larguier R Nouet S Lombard C and Bonnafous J-C (1994) J Biol Chem 269 20815-20818
36. Massot O Rousselle J-C Fillion M-P Grimaldi B Cloez-Tayarani I Fugelli A Prudhomme N Seguin L Rousseau B Plantefol M Hen R and Fillion G (1996) Mol Pharmacol 50 752-762.
37. Matsui H Lazareno S and Birdsall NJM (1995) Mol Pharmacol 47 88-98.
38. Mouillac B Chini B Balestre MN Elands J Trumpp-Kallmeyer S Hoflack J Hibert M Jard S and Barberis C (1995) J Biol Chem 270 25 771-25 777.
39. Oksenberg D Marsters SA O'Dowd BF Jin H Havlik S Peroutka SJ and Ashkenazi A (1992) Nature 360 161-163.
40. Parker EM Grisel DA Iben LG and Shapiro RA (1993) J Neurochem 60 380-383.
41. Pattabiraman N Namboodiri K Lowrey A and Gaber BP (1990) Protein Seq Data Anal 3 387-405.
42. Pearlman DA Case DA Caldwell JC Seibel GL Singh UC Weiner P and Kollman PA (1991) AMBER 4.0 University of California San Francisco.
43. Perez M Fourrier C Sigogneau I Pauwels PJ Palmier C John GW Valentin JP and Halazy S (1995) J Med Chem 38 3602-3607.
44. Perlman JH Laakkonen LJ Guarnieri F Osman R and Gershengorn MC (1996) Biochemistry 35 7643-7650.
45. Peroutka SJ (1994) Synapse 18 241-260.
46. Roth BL Choudhary MS and Khan N (1997) Mol Pharmacol 52 259-266.
47. Rouselle J-C Massott O Delepierre M Zifa E Rousseau B and Fillion G (1996) J Biol Chem 271 726-735.
48. Scheer A Fanelli F Costa T De Benedetti PG and Cotecchia S (1996) EMBO J 15 3566-3578.
49. Schertler GFX Villa C and Henderson R (1993) Nature 362 770-772
50. Schwartz TW (1994) Curr Opin Biotechnol 5 434-444.
51. Sealfon SC Chi L Ebersole BJ Rodic V Zhang D Ballesteros JA and Weinstein H (1995) J Biol Chem 270 16 683-16 688.
52. Sevcik J Dodson EJ and Dodson GG (1991) Acta Crystallogr Sect B 47 240.
53. Smolyar A and Osman R (1993) Mol Pharmacol 44 882-885.
54. Strader CD Fong TM Tota MR Underwood D and Dixon RAF (1994) Annu Rev Biochem 63 101-132.
55. Street LJ Baker R Castro JL Chambers MS Guiblin AR Hobbs SC Matassa VG Reeve AJ Beer MS Middlemiss DN et al (1993) J Med Chem 36 1529-1538.
56. Sylte I Edvardsen Ø and Dahl SG (1996) Protein Eng 9 149-160.
57. Trumpp-Kallmeyer S Hoflack J Bruinvels A and Hibert MF (1992) J Med Chem 35 3448-3462.
58. Tucek S and Proska J (1995) Trends Pharmacol Sci 16 205-212.
59. Unger VM and Schertler GFX (1995) Biophys J 68 1776-1786.
60. Van Rhee AM Fischer B Van Galen PJM and Jacobson KA (1995) Drug Des Discov 13 133-154.
61. Van Rhee AM and Jacobson KA (1996) Drug Dev Res 37 1-38.
62. Veldman SA and Bienkowski MJ (1994) FASEB J 8 A87(Abstract).
63. Weiner SJ Kollman PA Case DA Singh UC Ghio C Alagona G Profeta Jr S and Weiner P (1984) J Am Chem Soc 106 765-784.
64. Weiner SJ Kollman PA Nguyen DT and Case DA (1986) J Comput Chem 7 230-252.
65. Weinshank RL Zgombick JM Macchi MJ Branchek TA and Hartig PR (1992) Proc Natl Acad Sci USA 89 3630-3634.
66. Zgombick JM Schechter LE Kucharewitcz SA Weinshank RL and Branchek TA (1995) Eur J Pharmacol 291 9-15.
67. Zhang D and Weinstein H (1993) J Med Chem 36 934-938.
68. Zhou W Flanagan C Ballesteros JA Konvicka K Davidson JS Weinstein H Millar RP and Sealfon SC (1994) Mol Pharmacol 45 165-170.
69. Zifa E and Fillion G (1992) Pharmacol Rev 44 401-458.